AxoGen(AXGN) - 2024 Q3 - Quarterly Results

Axogen, Inc Reports Third Quarter 2024 Financial Results and Provides BLA Update ALACHUA and TAMPA, FL – November 7, 2024 – Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today reported financial results and business highlights for the third quarter ended September 30, 2024. Third Quarter Financial Results • Third quarter revenue was $48.6 million, a 17.9% increase compared to the third quarter of 2023. • In the third qua ...